0000899243-20-025437.txt : 20200916 0000899243-20-025437.hdr.sgml : 20200916 20200916204417 ACCESSION NUMBER: 0000899243-20-025437 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200916 FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CureDuchenne Ventures, LLC CENTRAL INDEX KEY: 0001824590 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 201179921 BUSINESS ADDRESS: STREET 1: 1400 QUAIL STREET STREET 2: SUITE 110 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 949-872-2552 MAIL ADDRESS: STREET 1: 1400 QUAIL STREET STREET 2: SUITE 110 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-09-16 0 0001818794 Dyne Therapeutics, Inc. DYN 0001824590 CureDuchenne Ventures, LLC 1400 QUAIL STREET SUITE 110 NEWPORT BEACH CA 92660 0 0 1 0 Series A Preferred Stock Common Stock 602972 D The Series A Preferred Stock is convertible into common stock on a 3.3169-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. CureDuchenne Ventures, LLC, By: /s/ Debra Miller, Chief Executive Officer 2020-09-16